Plus Therapeutics, Inc. (PSTV)
0.3027
-0.02
(-6.66%)
USD |
NASDAQ |
Feb 27, 16:00
0.3007
0.00 (0.00%)
After-Hours: 20:00
Plus Therapeutics Research and Development Expense (TTM) : 7.624M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Abbott Laboratories | 2.89B |
| Accuray, Inc. | 44.10M |
| Alphatec Holdings, Inc. | 75.82M |
| Boston Scientific Corp. | 2.052B |
| Apyx Medical Corp. | 3.546M |